欢迎来参加来自美国NIH Shawn Chen博士的学术报告：
报告题目：Cancer Molecular Imaging Probes
报告人：Shawn Chen. Ph.D, Senior Investigator & Chief of Laboratory of Molecular Imaging and Nanomedicine，NIH，USA.
报告时间：2011年7月26日（下周二）下午4:00
报告地点：国家传染病诊断试剂与疫苗工程技术研究中心三楼会议室（313室）
邀请人：夏宁邵 教授 

陈博士1993年和1996年在中国南京大学先后获得学士和硕士学位。随后移居美国，并在1999年在美国爱达荷大学化学系获得博士学位，之后先后在美国Syracuse雪城大学和华盛顿大学圣路易斯分校从事博士后研究。随后他进入美国南加州大学任放射学助理教授。2004年进入美国斯坦福大学，在Sanjiv Sam Gambhir教授领导下帮助建立斯坦福大学分子影像研究计划（the Molecular Imaging Program at Stanford（MIPS））。2008年被晋升为副教授。2009年夏，陈博士进入美国国家生物医学图像和生物工程研究所（NIBIB），并成为终身高级研究员和实验室主任。他首先领导的是正电子发射断层放射化学课题组，之后进一步发展建立了分子影像和纳米药物实验室（LOMIN）。

陈博士已发表超过280篇论文和大量的学术著作。他担任超过10个期刊的编委会成员，并担任“Theranostics”杂志的主编。陈博士的分子影像和纳米药物实验室（LOMIN）专门从事正电子发射断层扫描（PET）、单光子发射断层显像（SPECT）、核磁共振成像（MRI），光学（生物发光、荧光和拉曼）、对比增强超声、光声成像以及多模态成像的分子影像探针的合成研究。研究目标是发展可用于更好地研究生物学、开展疾病早期诊断、监测治疗反应、指导药物发现/开发的分子影像工具组合。陈博士的分子影像和纳米药物实验室（LOMIN）的特别重要的研究领域是用于生物标记检测的高灵敏度纳米传感器研究和可用于影像、基因或药物输送、治疗监测的theranostic纳米药物研究。

Dr. Chen received his B.S. in 1993 and M.S. in 1996 from Nanjing University, China. He then moved to the states and obtained his Ph.D. in chemistry from the University of Idaho in 1999. After two quick postdocs at Syracuse University and Washington University in St. Louis, he joined the University of Southern California as an Assistant Professor of Radiology. He then moved to Stanford University in 2004 to help build up the Molecular Imaging Program at Stanford (MIPS) under the directorship of Prof. Sanjiv Sam Gambhir. He was promoted to Associate Professor in 2008 and in the summer of 2009, he joined the intramural research program of the National Institute of Biomedical Imaging and Bioengineering (NIBIB) as a tenured senior investigator and lab chief. He took over the Positron Emission Tomography Radiochemistry Group and expanded it into the Laboratory of Molecular Imaging and Nanomedicine (LOMIN).

Dr. Chen has published over 280 papers and numerous books and book chapters. He sits on the editorial board of over 10 peer-reviewed journals and is the editor-in-chief of a new journal “Theranostics”. The Laboratory of Molecular Imaging and Nanomedicine (LOMIN) specializes in synthesizing molecular imaging probes for positron emission tomography (PET), single-photon emission computed tomography (SPECT), magnetic resonance imaging (MRI), optical (bioluminescence, fluorescence and Raman), contrast enhanced ultrasound, photoacoustic imaging as well as multimodality imaging. We aim to develop molecular imaging toolbox for better understanding of the biology, early diagnosis of diseases, monitoring therapy response, and guiding drug discovery/development. There is a special emphasis of LOMIN on high sensitivity nanosensors for biomarker detection and theranostic nanomedicine for imaging, gene and drug delivery, and monitoring of treatment. 

Xiaoyuan (Shawn) Chen, Ph.D.
资深研究员
分子影像和纳米药物实验室主任
Theranostics 期刊主编
国家生物医学成像和生物工程研究所
美国国立卫生研究院
Senior Investigator
Chief, Laboratory of Molecular Imaging and Nanomedicine
Editor-in-Chief, Theranostics
National Institute of Biomedical Imaging and Bioengineering
National Institutes of Health
Building 31, Room 1C22
31 Center Drive
Bethesda, Maryland 20892
Voice (301) 451-4246
Email: shawn.chen@nih.gov